Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950133-04-003114
Filing Date
2004-08-09
Accepted
2004-08-09 16:35:29
Documents
7
Period of Report
2004-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q w99903e10vq.htm 10-Q 203734
2 EXHIBIT 3.1 w99903exv3w1.htm EX-3.1 5806
3 EX-10.1 w99903exv10w1.htm EX-10.1 148223
4 EXHIBIT 31.1 w99903exv31w1.htm EX-31.1 6688
5 EXHIBIT 31.2 w99903exv31w2.htm EX-31.2 6685
6 EXHIBIT 32.1 w99903exv32w1.htm EX-32.1 3304
7 EXHIBIT 32.2 w99903exv32w2.htm EX-32.2 3338
  Complete submission text file 0000950133-04-003114.txt   380002
Mailing Address 8320 GUILFORD ROAD SUITE C 12111 PARKLAWN DR COLUMBIA MD 21046
Business Address 8320 GUILFORD RD STE C COLUMBIA MD 21046 3078543900
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

EIN.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26770 | Film No.: 04961778
SIC: 2836 Biological Products, (No Diagnostic Substances)